Scientists from Marconi Medical Systems and the Imperial College of London have developed a magnetic material that promises to improve MRI performance. The new material concentrates and shapes radio-frequency flux patterns used in data acquisition and is
Scientists from Marconi Medical Systems and the Imperial College of London have developed a magnetic material that promises to improve MRI performance. The new material concentrates and shapes radio-frequency flux patterns used in data acquisition and is less vulnerable than current materials to external interference. The capability of the substance as a flux guide has been used to remotely image a human finger.
The material was developed as part of a collaboration among the physics department of Imperial College, the Clinical Sciences Centre MR Unit of the Imperial Medical School, and Marconi Caswell in the U.K. The work led to the discovery of a new class of microstructured materials, which is part of a larger family called photonic band gap materials. The microstructured material now being developed by Marconi is designed specifically for use in MRI. It has a high magnetic permeability for RF fields but not for static fields. It also has applications as a magnetic screen and potentially as a magnetic lens.
Four Strategies to Address the Tipping Point in Radiology
January 17th 2025In order to flip the script on the impact of the radiology workforce shortage, radiology groups and practices need to make sound investments in technologies and leverage partnerships to mitigate gaps in coverage and maximize workflow efficiencies.
Can Generative AI Facilitate Simulated Contrast Enhancement for Prostate MRI?
January 14th 2025Deep learning synthesis of contrast-enhanced MRI from non-contrast prostate MRI sequences provided an average multiscale structural similarity index of 70 percent with actual contrast-enhanced prostate MRI in external validation testing from newly published research.
Can MRI-Based AI Enhance Risk Stratification in Prostate Cancer?
January 13th 2025Employing baseline MRI and clinical data, an emerging deep learning model was 32 percent more likely to predict the progression of low-risk prostate cancer (PCa) to clinically significant prostate cancer (csPCa), according to new research.